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Abstract: A major limitation of using synthetic scaffolds in tissue engineering applications is insufficient angiogenesis 
in scaffold interior. Bioactive borate glasses have been shown to promote angiogenesis. There is a need to investigate 
the biofabrication of polymer composites by incorporating borate glass to increase the angiogenic capacity of the fabri-
cated scaffolds. In this study, we investigated the bioprinting of human adipose stem cells (ASCs) with a polycaprolac-
tone (PCL)/bioactive borate glass composite. Borate glass at the concentration of 10 to 50 weight %, was added to a 
mixture of PCL and organic solvent to make an extrudable paste. ASCs suspended in Matrigel were ejected as droplets 
using a second syringe. Scaffolds measuring 10 × 10 × 1 mm3 in overall dimensions with pore sizes ranging from 100 – 
300 µm were fabricated. Degradation of the scaffolds in cell culture medium showed a controlled release of bioactive 
glass for up to two weeks. The viability of ASCs printed on the scaffold was investigated during the same time period. 
This 3D bioprinting method shows a high potential to create a bioactive, highly angiogenic three-dimensional environ-
ment required for complex and dynamic interactions that govern the cell’s behavior in vivo. 
Keywords: Eioprinting, biofabrication, human adipose-derived stem cell, MSCs, bioactive glass, polycaprolactone, 
scaffold, tissue engineering 
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1. Introduction 
ysfunctional or reduced blood supply is sym-
ptom of many health concerns, including di-
abetes, wound healing, and bone repair. Di-
abetes alone affects about 8.5% of the human popula-
tion and costs the world over $376 billion in medical 
related expenses each year[1]. Another problem asso-
ciated with reduced blood supply exists in bone grafts. 
Bone defects resulting from trauma, cancer, infection, 
or congenital skeletal abnormalities contribute to  
major surgeries performed every year. Autolog-
ous bone graft is still considered as the gold standard 
for most applications but creates donor site morbidi-
ty[2,3]. Allografts avoid these issues but have limited 
availability, concerns over immunogenicity, and po-
tential disease transmission[4]. Several materials in-
cluding biocompatible metals, bioceramics, and bio-
polymers are currently being investigated as candi-
dates for synthetic grafts. Additive manufacturing 
D 
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(AM), or popularly known as 3D printing, is a 
layer-by-layer material deposition process in which 
functional parts with complex shapes can be made 
which are otherwise difficult to manufacture. AM 
of biomaterials has shown that complex and strong 
implants can be made to treat different regions of bone, 
including load-bearing bone[5–7]. However, enginee-
red bone scaffolds have not been as successful as au-
tologous grafts thus far, largely due to insufficient vas-
cularization and reduced biomechanical function[8–9].  
The choices of materials and fabrication process are 
two significant factors that determine the success of 
engineered scaffolds. Many synthetic polymers and  
bioceramic materials have been used to make scaf-
folds for bone tissue engineering based on different 
AM techniques[10,11]. Since polymers are only bio-
compatible, attempts have been made to improve 
their bioactivity by adding different bioceramics to 
make polymer composites. Typically, such composites 
are prepared by mixing an inorganic bioceramic ma-
terial (in particle or fiber form) with a polymer which 
has been either heat melted or dissolved in an organic 
solvent[12]. The bioactivity of the eventual composite 
material not only depends on the choice of bioceramic 
(including bioactive glass, hydroxyapatite, etc.) but 
also depends on the method of composite preparation 
itself. Composite foams and films made by traditional 
fabrication methods such as solvent casting and par-
ticle leaching (SCPL) and thermally induced phase 
separation (TIPS) have reported improved water ab-
sorption and formation of hydroxyapatite[13]. However, 
it is difficult to control the scaffold porosity and shape 
using such methods. Scaffolds made with AM tech-
niques such as selective laser sintering and ink-jet 
printing have also shown improved bioactivity, but 
incorporating cells during fabrication akin to bio-
printing is not feasible due to processing limitations.  
3D bioprinting is a process that fabricates a “living” 
construct in a layer-by-layer fashion using a “bio-ink” 
(cells suspended in a medium) with or without addi-
tional materials. Creation of a 3D environment with 
spatial arrangement of cells and materials is essential 
for vascularization and complete implant integration 
with the surrounding tissue. 3D bioprinting techniques 
can be broadly classified into three categories: (i) la-
ser-assisted[14,15], (ii) inkjet-based[16], and (iii) extru-
sion-based printing[17]. Extrusion-based 3D bioprint-
ing is the most successful biofabrication process to 
date with a range of materials compatible with the 
process[17,18]. In an extrusion-based bioprinting pro-
cess, cells, hydrogels, and other materials are depo-
sited using one or multiple syringes with a pressure 
system. The pressure system consists of either a me-
chanical piston or a pneumatic pressure source (most-
ly compressed air) that is computer controlled. The 
material is extruded through a nozzle tip and the pro-
cess can deposit hydrogels with high cell density and 
minimal wastage in comparison to laser-assisted and 
ink-jet bioprinting techniques. Recent research has 
focused on creating living or cell-laden grafts for tis-
sues including bone, cartilage, and skeletal musc-
le[18–20]. In extrusion bioprinting, one syringe is typi-
callly devoted to melt the polymer and deposit the 
melt for scaffolding structure. However, research to 
date has only considered the melt-deposition process 
to print scaffolding and is limited to low melting point 
polymers. Therefore, it is essential to investigate alter-
nate approaches for printing other materials in order to 
develop more promising approaches in 3D bioprinting.  
The addition of bioactive glass to a biocompatible 
polymer transforms the 3D environment with its dis-
solution products by up-regulating the cell-cell and 
cell-matrix interactions, which promotes vasculariza-
tion. In the current study, we use a h ighly angiogen-
ic bioactive 13-93B3 borate glass because of its osteo 
stimulatory/conductive nature and anti-microbial pro-
perties[21]. In comparison to the more comm.on bioac-
tive silicate glass, such as 45S5 or 13-93 glass, 13- 
93B3 has a higher reaction rate (5–10 times faster than 
silicate glasses) and resorbs (60 to 70% wt. loss) in a 
few days to weeks[9]. Ion release from the borate glass 
has been linked to the wound healing nature of this 
glass, with the boron ions in particular leading to the 
angiogenic effects, which are marginal in the silicate 
glasses[22]. The borate glass was recently approved by 
the Food and Drug Administration of the United 
States for human use with trade name Mirragen™ 
Advanced Wound Matrix. 
Mesenchymal stem/progenitor cells (MSCs) have be-
en used for cell therapy and in tissue engineering be-
cause of their ability to differentiate into multiple me-
senchymal lineages in vitro, immune modulatory ef-
fects, and angiogenic capacity[23,24]. MSCs have been 
isolated from several tissues, including the bone mar-
row (BMSCs), adipose tissue (ASCs), and skin tis-
sue[25–28]. The frequency of MSCs in adipose tissue is 
much higher than the more commonly studied source 
of bone marrow, yielding 100 to 500 times more cells 
per tissue volume[29–30]. ASCs have similar self-ren-
ewal abilities, common surface epitopes, growth ki-
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netics, and cytokine expression profiles to BSCs. With 
the addition of ASCs, the scaffold is expected to im-
prove its biomechanical and biological properties 
for better repair of the target tissue. In the current 
study, we investigate the feasibility of scaffold fabri-
cation using a two syringe system with a PCL/borate 
glass composite dissolved in an organic solvent as a 
scaffold material, whilst simultaneously printing cells 
suspended in Matrigel, which is a gelatinous protein 
mixture representing basement membrane. Included in 
this study are the effect of borate glass content on the 
composite paste printability, the scaffold tempor-
al bioactivity, its degradation in culture media, and 
ASC viability in the scaffold. 
2. Materials and Methods 
2.1 Preparation of PCL/13-93B3 Borate Glass 
Composite Material 
Polycaprolactone (Sigma-Aldrich, St. Louis, Missouri, 
USA) was dissolved in chloroform (CF) (Sigma-Ald-
rich, St. Louis, Misouri, USA) in a covered glass con-
tainer with the help of a stirrer at ~5 0°C.ThePCL 
weight to CF volume ratio (grams:mL) was varied from 
1:1 to 5:4 to determine the ideal ratio for printing. An 
appropriate ratio was established by visually inspecting 
the paste and through filament extrusion using a digital 
syringe dispenser (Loctite®, Henkel North America, 
Rocky Hill, Connecticut, USA). Then, 13-93B3 glass 
(Mo-Sci Corporation, Rolla, Missouri, USA) (nominal 
composition – 53% B2O3, 20% CaO, 12% K2O, 6% 
Na2O, 5% MgO, 4% P2O5 in weight percentage) with 
~20 µm particle size was added to the PCL:CF mix in 
five different weight percentages in increments of 10, 
ranging from 10% to 50%. A magnetic stirrer was used 
to uniformly mix the composite paste, and no settling 
of the glass particle precipitate was observed before 
transferring the paste to a syringe. Each ratio was tested 
using a digital syringe dispenser at air pressure ranging 
from 10 to 50 psi and with nozzle tip diameter ranging 
from 110 to 600 µm (32 G to 20 G). 
2.2 Preparation of Bio-ink 
Frozen vials of approximately 1 × 106 ASCs were ob-
tained from three separate donors (LaCell, New Or-
leans, Louisiana, USA). Vials were unthawed, plated 
on 150 cm2 culture dishes (Nunc, Rochester, New 
York, USA) in 25 mL complete culture media (CCM), 
and incubated at & with5%humidified CO2.The 
CCM contained 10% fetal bovine serum (Corning,  
Manassas, Virginia, USA), 1% 100× L-glutamine (GE 
Life Sciences, Logan, Utah, USA), 2% 100× antibio-
tic/antimycotic (GE Life Sciences, Logan, Utah, USA, 
and minimum essential medium alpha modified 
(α-MEM) (Sigma-Aldrich, St. Louis, Missouri, USA). 
After 24 hours, the media was removed and adherent, 
viable cells were washed twice with PBS, harvested 
with 0.25% trypsin/1mM EDTA (Gibco,Grand Island, 
New York, USA), and replated at 100 cells/cm2 in 
CCM. The media was changed every 3 to 4 days. For 
all experiments, sub-confluent cells (≤70% conflu-
ent) between passages 2 and 6 were used. To prepare 
the bio-ink, ASCs were suspended at a concentration of 
10×106 cells per mL of Matrigel (Corning, Bedford, 
Massachusetts, USA) diluted to 9 mg/mL in phos-
phate buffered saline (PBS). The bio-ink was then 
transferred to a tap ered nozzle tip (30G) which was 
stored on ice during the entire non-printing time. 
The bio-ink was gently pipetted to obtain a uniform 
distribution of cells just before printing. Matrigel was 
used in this work as it resembles the complex extra 
cellular environment found in many tissues. 
2.3 Scaffold Fabrication  
A square scaffold measuring 10 mm in length was 
printed with 0°–90° orientation of the filaments in 
alternate layers. The schematic in Figure 1A shows 
the printing set-up and Figure 1B depicts the printing 
process. A custom modified cartesian 3D printer 
(Geeetech, Prusa I3 A Pro) with two additional sy-
ringes controlled by digital dispensers was used for 
fabrication. The G-code for nozzle movement was 
written to print in a 0°–90° pattern to obtain rectangular 
pores. The printing parameters such as air pressure, 
filament spacing, layer height, and printing speed were 
identified based on visual inspection and optical mi-
croscopic images after the first and second layer 
printing for different paste compositions. To determine 
the printing parameters for Matrigel, an experiment 
was conducted by varying the nozzle tip distance from 
the glass slide, droplet dispensing time, and air pres-
sure. Fluorescent images of the droplets were taken 
and ImageJ software was utilized to quantify the 
number of cells and cell distribution in each fluores-
cent image. A tapered nozzle tip (30 G) with 160 µm 
orifice provided the suitable droplet size (~400 µm) at 
10 psi and 0.035 s dispensing time for deposition on the 
filament. While some droplets fell to the surrounding 
pores, most of the droplets stayed on the filament be-
fore the Matrigel was allowed to cross-link at room 
temperature. The fabrication experiments were  
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Figure 1. (A) Schematic of the printing set-up. One syringe contained PCL, 13-93B3 glass, and chloroform, while the other syringe 
contained ASCs suspended in Matrigel. (B) The composite layers are printed in 0o–90o pattern using one syringe while a second sy-
ringe prints the bio-ink droplets on top of every other layer. 
 
performed at room temperature (64°F) where the vari-
ation in relative humidity (58–60%) was not consi-
dered to be a major factor. 
2.4 Degradation of PCL/13-93B3 Glass Composite 
The degradation of the PCL/13-93B3 composite was 
studied on s caffolds measuring (10×10×1) mm3. The 
printed scaffolds were dried at least for one day for 
complete evaporation of CF. Before immersion, the 
scaffolds were weighed and 300 mL of α-MEM was 
used for 1 g of the scaffold for soaking. Scaffolds 
were immersed in high density polyethylene (HD-
PE) bottles containing α-MEM and stored in an incu-
bator maintained at 37°Cfor different time intervals 
ranging from 1 da y to 14 days. After removal, the 
scaffold was gently washed with de-ionized (DI) water, 
and dried overnight. The dried scaffold was weighed 
to calculate the weight loss percentage. A sample size 
of three for each time interval was used in the study 
and the results were reported as mean ± standard dev-
iation. 
2.5 Cell Viability and Proliferation 
The effect of chloroform evaporation from the scaffold 
on the viability of the ASCs was studied by deposit-
ing bio-ink droplets on the printed composite filaments. 
For this study, three composite layers were printed on a 
two-chamber microscope slide (Thermo Fischer 
Scientific, Rochester, New York, USA) and allowed to 
dry for ~2 mins before depositing a layer of bio-ink 
droplets. The Matrigel in bio-ink was allowed to po-
lymerize at r oom temperature for 20 minutes, then 1 
mL of CCM was added. The slides were then incubated 
at 37°Cwith5%humidified CO2 for three time inter-
vals of 2 hrs, 1 week, and 2 weeks. The medium was  
changed every three days. After each time interval, the 
CCM was removed and the cells were stained using the  
Live/Dead Cell Imaging Kit (ref. R37601, Eugene, 
Oregon, USA), incubated for 15 minutes at room 
temperature and examined under a fluorescent micro-
scope (Olympus IX51, Melville, New York, USA).  
2.6 Scaffold Characterization 
Optical microscopic images were used to measure the 
filament width and pore size with at least five mea-
surements and the results were reported as mean ± 
standard deviation. Samples were sputter coated with 
gold/palladium (Au/Pd) for 60 s before performing 
scanning electron microscopy (SEM). SEM (Hitachi 
S-4700 FESEM, Hitachi Co., Tokyo, Japan) images 
were taken to evaluate the surface morphology of the 
scaffolds, internal structure of the filaments, and for-
mation of hydroxyapatite-like material on the scaffold 
surface. Scans were run from 2θ values ranging from 
10° to 80° using Cu Kα radiation (λ = 0.154056 nm) 
for X-ray diffraction (XRD) analysis (Philips X-Pert, 
Westborough, MA) on the as-received PCL, as-printed 
PCL/B3 glass scaffold, and the scaffold after α-MEM 
immersion to determine the changes in the crystal-
line/amorphous nature of the material. 
3. Results 
3.1 Fabrication of PCL/13-93B3 Glass Composite 
Scaffolds 
The initial set of printing tests included depositing 
single layers using the composite paste with 10 wt. % 
of 13-93B3 glass. A minimum air pressure of 30 psi 
was required to extrude the paste through a 260 μm 
(25G) nozzle tip. Larger tips (>260 µm) resulted in 
thick filaments which took longer time (>5 min) to dry 
and smaller tips (<260 µm) consistently caused clog-
ging issues. The roundness of the filament improved 
with increasing glass content along with the paste  
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viscosity. The minimum air pressure required to ex-
trude the paste increased when glass content was in-
creased from 10 wt. % to 30 wt. %. At higher glass 
content (40 wt. % and 50 wt. %), the nozzle clogged 
during fabrication. Therefore, additional CF (about 1 
mL) was added to the paste to reduce the viscosity for 
clog-free extrusion using the 25G tip. The 13-93B3 
glass weight percentage and PCL: CF ratios used to 
make composite pastes are shown in Table 1. The fi-
nal printing parameters used to fabricate the compo-
site scaffolds containing 50 wt. % 13-93B3 glass con-
tent is also provided in 7DEOH. 
 







(g to mL) 
Final Printing Parameters 
(using C5 paste) 
C1 10 5:3 Printing speed – 8 mm/s 
C2 20 5:3 Dwell time – 2 min 
C3 30 5:3 Layer height – 0.1 mm 
C4 40 5:4 Air pressure – 30 psi 
C5 50 5:4 Nozzle tip – 260 µm 
 
A filament width of 397±10 μm was measured for 
scaffolds printed with the C5 paste while average pore 
size is dependent on the filament spacing. A filament 
spacing of 600 µm provided square pores measuring 
~160 µm (Figure 2A). In comparison, the average 
pore size was ~350 µm for scaffolds fabricated with 
800 µm filament spacing. Figure 2B shows scaffolds 
fabricated with 800 µm filament spacing. Warping 
was predominant while fabricating scaffolds with C1 
and C2 pastes and this led to difficulty in printing after 
about 8 l ayers; see warped C1 and C2 scaffolds in 
Figure 2B. The warpage in scaffolds fabricated with 
C3 paste was less pronounced and a scaffold height of 
0.8 mm (10 layers) was obtained. Overall, the best 
results were achieved for scaffolds fabricated with C5 
paste as they were successfully printed to 1 mm height 
(12 layers). The scaffold fabricated with C5 paste had 
enough strength to be safely handled for subsequent 
degradation and in vitro assessment. 
SEM images of scaffolds fabricated with C5 paste 
are shown in Figure 3. Figures 3A and 3B show the 
surface morphology of the filament. Glass particles 
are conspicuously absent from the surface of filaments. 
No pores on the filament surface were detected even 
when observed at a 2000× magnification. Figures 3C 
and 3D show the filament cross-sectional surface. 
Glass particles dispersed in the PCL matrix can be 
seen in the interior. The dissolved PCL in chloroform 
encloses the glass particles and surface tension ef-
fects between the nozzle tip and PCL during extrusion 
appear to have caused the presence of only PCL on the 
surface.  
3.2 Degradation and Bioactivity of PCL/13-93B3 
Glass Composite 
Recent studies suggest that cell culture medium can be 
used as an alternative to simulated body fluid (SBF) to 
evaluate the bioactivity of the materials, with no sig-
nificant differences in the formation of hydroxyapatite 
(HA)[31]. We studied the degradation of the compo-
site by soaking the scaffolds made with C5 paste in 
α-MEM for 1, 3, 7, and 14 days. The scaffold 
weight before and after immersion (post drying) was 
recorded at each time interval. No significant weight 
loss was observed for 3 days (less than 1%), and the 
measured weight loss was 10.7±5% at 7 days and 
23.2±4% at 14 days. As PCL takes a longer time to 
degrade, the weight loss measured is due to the ionic 
dissolution of the 13-93B3 borate glass. Formation of 
flower like florets, which typically represent HA-like 
material, was observed on the filament surface as 
shown in Figures 4A and 4B.  
The energy-dispersive X-ray spectroscopy (EDX) 
analysis indicated the presence of calcium (Ca), 




Figure 2. (A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold fabricated with C5 paste. (B) Scaffolds 
fabricated with different composite pastes (C1 to C5). The bottom panel shows scaffold warpage with an arrow indicating space be-
tween scaffold and slide. Warpage was minimal in C3/C4 scaffolds and completely absent in C5 scaffolds. 
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Figure 3. SEM images of the 50:50 PCL/13-93B3 glass scaffold. (A) Low magnification (30×) image of scaffold surface showing 
filaments and pores, (B) smooth surface morphology of filament (2000× magnified image of the region marked in (A), (C) fractured 
surface of a broken filament with PCL matrix and glass particles, (D) magnified image of the region marked in (C) with arrows indi-




Figure 4. SEM images of the 50:50 PCL/13-93B3 glass scaffold after immersion in α-MEM for 14 days. (A) ~1 µm thick layer was 
formed on the filament surface (a piece of the reacted layer indicated by arrow raised to expose the polymer beneath), (B) magnified 
image (8000×) of the area marked in (A) showing the formation of HA-like florets on the filament. 
 
surface of the scaffold after 14-day immersion in 
α-MEM. Figure 5A shows the result of the line scan 
performed on the surface indicating the changes in 
elemental composition in atomic weight percentage. 
In particular, carbon (C), Ca, P, and O are plotted to 
provide a better comprehension of the reacted surface. 
Signals of sodium (Na) and magnesium (Mg) were 
also detected but in very small amounts. All the sig-
nals correspond to K series emissions (Kα and Kβ). 
The location of the scan region is shown by an arrow 
line in Figure 5B. The location was selected such that 
a scan line (~70 µm long) has to start on a r eacted 
surface, pass through the exposed PCL surface, and 
end on the reacted surface. As signals were recorded, 
the presence of elements was confirmed. It can be ob-
served that the percentage of Ca and P drops to zero  
and amount of O decreases as well when scanning the 
PCL surface (from ~30 µm to ~50 µm in Figure 5A). 
The presence of Ca, P, and O indicates that the glass 
has reacted and formed HA-like material on the  
scaffold surface.  
3.3 Effect of Chloroform Evaporation on ASC 
Viability 
The viability of ASCs was studied by performing a 
live/dead assay after incubating the samples for 24 
hours, and 1 week. The viability of cells after 24 hours 
was 70±10% (Figures 6A and 6B). After 1 week, the 
viability of cells was 58±11% (Figures 6C and 6D). 
4. Discussion 
A variety of solvents are available to dissolve different  
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Figure 5. EDX analysis on the surface of the 50:50 PCL/13-93B3 glass scaffold soaked in α-MEM. (A) Graph of line scan data 
showing the variation in Ca, P, O, and C in atomic weight percentages; presence of Ca, P, and O on the reacted surface confirms the 




Figure 6. Live/Dead images of ASCs suspended in Matrigel and printed on the 50:50 PCL/13-93B3 glass composite scaffold. Im-
aged after (A–B) 24 hours, and (C–D) 1 week. The dotted lines indicate the outline of the filament and dark space indicates the pore. 
 
biopolymers[32]. Extrusion of solvent dissolved poly-
mer and bioactive glass is safe at r oom temperature 
and reduces the process complexity since there is no 
need for temperature control. This method can be 
adopted by most of the existing open-source 3D prin-
ters available in the market. Chloroform (CF) was 
used in this study because it provides: (i) a h igh vis-
cosity paste, making it suitable for extrusion-based 3D 
printing, (ii) fast evaporation (~2 min), making it safe 
to print ASCs in Matrigel during the fabrication 
process, (iii) filament porosity for accelerated glass 
dissolution to the surrounding, and (iv) faster poly-
mer bulk degradation by exposing the interior of fila-
ment. To address the issue of safety with the use of CF 
while depositing bio-ink, we performed cell viability 
study on scaffolds made with C3 (30% glass) and C5 
(50% glass) composite pastes using a live/dead assay. 
The results showed healthy living A SCs on P CL/13- 
93B3 glass filaments even after one week of incubation. 
An important aspect in extrusion bioprinting is to 
create a scaffolding structure that supports cells and 
provides shape and mechanical integrity. Extru-
sion bioprinters typically have more than one syringe, 
with one of the syringes devoted to print scaffolding 
structure. The options utilized for this purpose include 
melt-deposition of polymer and fused deposition 
modeling (FDM) with a polymer wire feed. Because 
of high temperatures involved in many melting bio-
polymers such as polylactic acid (PLA, with a melting 
point of 160°C), PCL has become one of the most 
widely used polymers owing to its lower melting point 
of 60 °C. For 3D printing, PCL is an attractive op-
3D bioprinting of stem cells and polymer/bioactive glass composite scaffolds for bone tissue engineering 
 
60 International Journal of Bioprinting (2017)–Volume 3, Issue 1 
tion because of its good rheological and viscoelastic 
properties. Despite its slow degradation rate (~2 years 
depending on the molecular weight), PCL has been 
widely used to fabricate scaffolds for bone tissue en-
gineering[33]. But for other tissue engineering applica-
tions which require faster degrading of scaffolding 
structure, this may become an impediment. Since 
FDM fabricated polymer scaffolds are only biocom-
patible, another issue would be to make the scaffold-
ing structure bioactive by incorporating bioceramic 
materials. In the past, some researchers made a poly-
mer-bioactive glass wire for use by the FDM process 
to fabricate polymer-bioactive glass scaffolds[34]. 
However, no significant improvement in bioactivity 
and cell growth has been reported, which could be due 
to inadequate ionic dissolution of the glass into the 
surrounding environment. This makes the FDM and 
melt-deposition options unattractive for fabrication of 
polymer-glass composite scaffolds. In our current 
study, polymer (PCL) was dissolved in a s olvent 
(chloroform), mixed with a bioactive glass (13-93B3 
glass), and then extruded to fabricate the scaffold. Our 
weight loss results showed that most of the 13-93B3 
glass has reacted in 2 weeks. The schematic in Fig-
ure 7 explains the difference in the glass dissolution 
from filaments printed using (A) FDM or melt-extrus-
ion process and (B) solvent-based extrusion process. 
Fine cracks on the filament surface which are a couple 
of microns wide and up to ten microns or more in 
length can be observed in Figure 7C. Those cracks 
are believed to aid glass dissolution when the scaffold 
is immersed in the culture medium. 
Our degradation results also show a controlled re-
lease of 13-93B3 glass over a period of two weeks 
into the surrounding solution. In the past, composite 
thin films have been made using PCL/13-93B3 glass 
and PCL/45S5 glass with different amount of glass 
content[35]. The degradation data of such thin films 
indicate that the entire glass almost completely dis-
solves in about three days. The graph shown in Figure 
8 compares the weight loss percentage of the 
PCL/13-93B3 glass thin films (80 µm) with that of the 
current study. Almost entire 13-93B3 glass was 
reacted in about 3 da ys from thin films. The faster 
degradation in composite films could be due to the 
thickness of the film. The scaffolds in the current 
study are made by filaments which are about 400 µm 
in diameter and have no surface pores that explained 
the very little glass dissolution in three days. However, 
the water absorbing potential of polymers in general 
was reportedly found to improve after the addition 
of bioceramic filler materials such as HA and even bio-
active glass[12]. In our study, the glass dissolution in-




Figure 7. Schematic highlighting the difference in two methods of extrusion printing. (A) Melt-deposition of polymer-glass compo-
site resulting in a dense filament and low bioactivity, (B) solvent-based extrusion printed composite resulting in a porous filament 
with high bioactivity, (C) SEM images showing surface cracks on the filament indicated by arrows in (i) and (ii), and pores inside the 
filament measuring less than 10 µm are also indicated by arrows in (iii). 
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believed to be due to the internal porosity of the fila-
ment created after the CF evaporation and also glass 
dissolution creating more porosity. The entire B2O3 
present in the borate glass (53 B2O3, 20 CaO, 12 K2O, 
6 Na2O, 5 MgO, 4 P2O5
 in composition by w eight %) 
completely dissolves into surrounding environment, 
and the rest oxides with the exception of MgO partic-
ipate in the formation of HA. By neglecting the 
weight of HA formed, it can  be theoretically calcu-
lated that there is about ~35% weight loss for the 
scaffold, assuming a complete 13-93B3 glass dissolu-
tion in 50:50 PCL/13-93B3 composite. In this study, 
the weight loss for 50:50 PCL/13-93B3 composites-
caffold was ~23%, indicating that ~70% of the 13-93B3 
glass present in the scaffold had reacted in 14 days. 
This degradation vs. time characteristic can be used to 
develop a controlled degradation of 3D scaffold that 
is beneficial in certain tissue engineering applications, 




Figure 8. Weight loss percentage comparison of 3D printed 
50:50 PCL/13-93B3 glass composite scaffolds vs. thin film 
composite made using PCL, CF, and 50% 13-93B3 glass[35]. 
 
The reacted layer formed on the scaffold surface 
was ~1 µm thick and not completely uniform (dense 
collection of florets can be seen in Figure 4C). XRD 
analysis was performed to confirm the presence of 
crystalline HA but the XRD pattern obtained on a 14 
day soaked scaffold could not match the known HA 
crystalline peak. This is believed to be because of 
formation of amorphous HA or non-stoichiometric 
HA, which is not uncommon in such cases. Figure 9 
shows XRD patterns of the as-received 13-93B3 glass, 
PCL/13-93B3 glass composite scaffold, and the com-
posite scaffold after soaking in α-MEM for 2 weeks. 
The semi-crystalline nature of the PCL was confirmed 
with characteristic peaks (marked by *) and amorph-
ous profile of 13-93B3 glass with no sharp peaks and 
characteristic hump can be observed in the XRD pat-
terns shown in Figure 9. There are additional peaks 
observed for the α-MEM soaked sample which could 
not be identified to a known material in the database 
(marked by †). However, the typical amorphous hump 
seen in glass was not existent in the soaked sample, 
indicating that most of the 13-93B3 glass in the scaf-




Figure 9. XRD patterns of (A) 50:50 PCL/13-93B3 glass 
composite scaffold soaked in α-MEM for 14 days, (B) 
PCL/13-93B3 glass scaffold, (C) as-received PCL showing a 
semi-crystalline nature with characteristic peaks marked by *, 
and (D) as-received 13-93B3 glass with characteristic amorph-
ous hump (25° to 35° and 40° to 50°).  
 
It is known that pore size is an important parameter 
of the scaffold that could potentially affect the bone 
growth after implantation, and it has been reported 
that pore size in the range of 100 to 300 µm is benefi-
cial for bone growth[9]. The scaffolds we fabricated 
have pores in this range. Moreover, the ASCs when 
co-cultured with 2.5 mg of 13-93B3 glass per 1 mL of 
culture media in standard culture conditions show os-
teogenic differentiation with no detrimental effects. 
Therefore, the scaffolds fabricated using solvent-based 
extrusion 3D bioprinting developed as in the present 
study have a high potential for non-load-bearing bone 
repair applications.  
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5. Conclusion 
This study investigated the feasibility of fabricating a 
scaffold with polycaprolactone/bioactive borate glass 
composite using a solvent based extrusion 3D printer 
integrated with printing of human ASCs suspended in 
Matrigel during the scaffold fabrication process. 
Printing process parameters were identified for the 
composite and bio-ink to fabricate a (10×10×1) mm3 
ASC-laden scaffold with pore sizes ranging from 100 
to 300 µm suitable for bone tissue engineering. In 
comparison to the conventional melt-deposition extru-
sion 3D bioprinting, the degradation of polymer/bioa-
ctive glass scaffolds showed a c ontrolled release 
of bioactive glass with ~23% weight loss in two 
weeks. Formation of hydroxyapatite-like crystals on 
the surface of the scaffold after soaking in culture me-
dia for up to two weeks shows the strong bioactivity 
of the fabricated composite scaffold and its high po-
tential for bone repair. The live/dead assay showed 
more than 60% viable ASCs on the scaffold after 1 
week of incubation, with minimal negative effects 
from chloroform evaporation on the cells. The results 
of this study show the high potential of the sol-
vent-based extrusion 3D bioprinting process to fabri-
cate a scaffold with cells and polymer composites for 
tissue engineering applications. 
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